Wells Fargo & Company Raises Mettler-Toledo International (NYSE:MTD) Price Target to $1,450.00

Mettler-Toledo International (NYSE:MTD) had its target price raised by stock analysts at Wells Fargo & Company from $1,400.00 to $1,450.00 in a report issued on Monday,Benzinga reports. The brokerage currently has an “equal weight” rating on the medical instruments supplier’s stock. Wells Fargo & Company‘s price objective would indicate a potential upside of 4.54% from the company’s current price.

Other research analysts also recently issued research reports about the company. Barclays boosted their target price on Mettler-Toledo International from $1,350.00 to $1,600.00 and gave the company an “overweight” rating in a research note on Monday, November 10th. The Goldman Sachs Group started coverage on Mettler-Toledo International in a research note on Tuesday, December 9th. They issued a “neutral” rating and a $1,475.00 price target for the company. Weiss Ratings restated a “hold (c+)” rating on shares of Mettler-Toledo International in a report on Monday, December 8th. Citigroup lifted their target price on shares of Mettler-Toledo International from $1,600.00 to $1,700.00 and gave the company a “buy” rating in a research note on Monday, November 10th. Finally, JPMorgan Chase & Co. boosted their target price on shares of Mettler-Toledo International from $1,200.00 to $1,285.00 and gave the stock a “neutral” rating in a research report on Thursday, October 9th. Six analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. According to MarketBeat, Mettler-Toledo International currently has an average rating of “Hold” and a consensus price target of $1,441.67.

Mettler-Toledo International Stock Performance

MTD stock opened at $1,387.07 on Monday. The firm has a 50 day simple moving average of $1,405.14 and a 200 day simple moving average of $1,297.26. Mettler-Toledo International has a 52 week low of $946.69 and a 52 week high of $1,525.17. The stock has a market cap of $28.34 billion, a P/E ratio of 34.59, a P/E/G ratio of 4.56 and a beta of 1.40.

Mettler-Toledo International (NYSE:MTD) last released its quarterly earnings data on Thursday, November 6th. The medical instruments supplier reported $11.15 earnings per share for the quarter, beating the consensus estimate of $10.62 by $0.53. Mettler-Toledo International had a net margin of 21.20% and a negative return on equity of 426.96%. The firm had revenue of $1.03 billion for the quarter, compared to analyst estimates of $997.36 million. During the same quarter in the prior year, the business earned $10.21 EPS. The company’s revenue for the quarter was up 7.9% compared to the same quarter last year. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS and its FY 2025 guidance at 42.050-42.250 EPS. Sell-side analysts predict that Mettler-Toledo International will post 42.71 EPS for the current year.

Insider Transactions at Mettler-Toledo International

In other Mettler-Toledo International news, insider Gerry Keller sold 236 shares of the company’s stock in a transaction that occurred on Friday, November 21st. The stock was sold at an average price of $1,418.58, for a total transaction of $334,784.88. Following the completion of the sale, the insider owned 159 shares of the company’s stock, valued at $225,554.22. This represents a 59.75% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Elisha W. Finney sold 474 shares of the stock in a transaction that occurred on Monday, November 10th. The shares were sold at an average price of $1,433.57, for a total value of $679,512.18. Following the transaction, the director owned 311 shares in the company, valued at approximately $445,840.27. This trade represents a 60.38% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders sold 19,565 shares of company stock worth $28,683,737. 0.77% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of the company. Vanguard Group Inc. boosted its holdings in Mettler-Toledo International by 1.3% during the third quarter. Vanguard Group Inc. now owns 2,591,173 shares of the medical instruments supplier’s stock valued at $3,180,950,000 after acquiring an additional 34,466 shares during the period. Bank of New York Mellon Corp lifted its position in shares of Mettler-Toledo International by 71.3% during the 2nd quarter. Bank of New York Mellon Corp now owns 904,264 shares of the medical instruments supplier’s stock worth $1,062,257,000 after purchasing an additional 376,419 shares during the last quarter. Capital International Investors boosted its stake in Mettler-Toledo International by 1.2% during the 3rd quarter. Capital International Investors now owns 859,559 shares of the medical instruments supplier’s stock valued at $1,055,203,000 after purchasing an additional 10,395 shares during the period. Alliancebernstein L.P. boosted its stake in Mettler-Toledo International by 10.7% during the 3rd quarter. Alliancebernstein L.P. now owns 793,927 shares of the medical instruments supplier’s stock valued at $974,633,000 after purchasing an additional 76,478 shares during the period. Finally, Geode Capital Management LLC grew its holdings in Mettler-Toledo International by 0.6% in the 2nd quarter. Geode Capital Management LLC now owns 581,847 shares of the medical instruments supplier’s stock valued at $681,489,000 after buying an additional 3,383 shares during the last quarter. Institutional investors and hedge funds own 95.07% of the company’s stock.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.